Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies

Clinical trial NCT07309770 · RECRUITING

Trial details

NCT number: NCT07309770
Sponsor: Sheng Zhang
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Urachal Cancer Advanced Solid Tumor Cancer Antibody-drug Conjugates

Start date: 2025-12-18
Primary completion: 2027-09-11
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.